Apogee Therapeutics, Inc. · NASDAQ:APGE

Henderson Michael Thomas sold 20,000 Apogee Therapeutics, Inc. shares (Form 4)

Traded Jul 8 to Jul 10, 2026 · Filed Jul 10, 2026

From Jul 8 to Jul 10, 2026, Henderson Michael Thomas (Director, Chief Executive Officer) sold 20,000 Apogee Therapeutics, Inc. shares at US$133.63 for US$2.67M under a trading plan, leaving 920,941 shares. Filed Jul 10, 2026 (Form 4).

Sold
20,000 shares
Price
US$133.63
Value
US$2.67M
Holding after
920,941 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 8, 2026Common StockSale20,000US$133.63995,987Direct
Jul 10, 2026Common StockGift75,046920,941Direct

Source

View original at SEC

Related